HEALTHCARE SUPPLY CHAIN ASSOCIATION — Lobbying Disclosure | Poliscope

HEALTHCARE SUPPLY CHAIN ASSOCIATION

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$5.8M

Filings

153

Firms Hired

Active Period

2008–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$440,000	6	2
2025	$600,000	6	2
2024	$610,000	12	3
2023	$690,000	8	2
2022	$480,000	8	2
2021	$390,000	10	3
2020	$480,000	8	2
2019	$680,000	8	2
2018	$680,000	8	2
2017	$640,000	8	2
2016	$160,000	12	4
2015	—	8	2
2014	—	8	2
2013	—	9	2
2012	—	8	2
2011	—	8	2
2010	—	8	2
2009	—	7	2
2008	—	3	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
HEALTHCARE SUPPLY CHAIN ASSOCIATION	$5,850,000	44
VAN HEUVELEN STRATEGIES, LLC	—	52
SmithBucklin Corporation	—	32
THE VOGEL GROUP	—	16
VENN STRATEGIES	—	5
CORCORAN STREET GROUP	—	4

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	144
SENATE	144
Health & Human Services, Dept of (HHS)	28
Food & Drug Administration (FDA)	23
Federal Trade Commission (FTC)	14
Centers For Medicare and Medicaid Services (CMS)	11
Drug Enforcement Administration (DEA)	10
White House Office	7
Government Accountability Office (GAO)	4
Office of Management & Budget (OMB)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	151
Medicare/Medicaid	Medicare/Medicaid	68
Trade (domestic/foreign)	Trade (domestic/foreign)	21
Manufacturing	Manufacturing	21
Homeland Security	Homeland Security	3
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	2

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · fourth_quarter · Firm: CORCORAN STREET GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices,drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile, and responding to natural disasters; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 -Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $50,000

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · fourth_quarter · Firm: CORCORAN STREET GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices,drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile, and responding to natural disasters; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 -Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $50,000

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · fourth_quarter · Firm: CORCORAN STREET GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices,drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile, and responding to natural disasters; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 -Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $50,000

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · fourth_quarter · Firm: CORCORAN STREET GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices,drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile, and responding to natural disasters; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 -Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $50,000

Matched citations: S.1339

Show 21 more cited filings

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · third_quarter · Firm: CORCORAN STREET GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices,drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile, and responding to natural disasters; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 -Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $50,000

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · third_quarter · Firm: CORCORAN STREET GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices,drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile, and responding to natural disasters; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 -Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $50,000

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · third_quarter · Firm: CORCORAN STREET GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices,drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile, and responding to natural disasters; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 -Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $50,000

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · third_quarter · Firm: CORCORAN STREET GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices,drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile, and responding to natural disasters; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 -Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $50,000

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · third_quarter · Firm: THE VOGEL GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management; Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: —

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · third_quarter · Firm: THE VOGEL GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management; Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: —

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · third_quarter · Firm: THE VOGEL GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management; Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: —

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · third_quarter · Firm: THE VOGEL GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management; Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: —

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · second_quarter · Firm: CORCORAN STREET GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices,drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and theStrategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 -Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $20,000

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · second_quarter · Firm: CORCORAN STREET GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices,drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and theStrategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 -Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $20,000

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · second_quarter · Firm: CORCORAN STREET GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices,drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 -Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: —

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · second_quarter · Firm: THE VOGEL GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management; Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $30,400

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · second_quarter · Firm: THE VOGEL GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management; Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $30,400

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · second_quarter · Firm: THE VOGEL GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management; Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $30,400

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · second_quarter · Firm: THE VOGEL GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management; Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $30,400

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · first_quarter · Firm: THE VOGEL GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management; Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $45,600

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · first_quarter · Firm: THE VOGEL GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management; Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $45,600

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · first_quarter · Firm: THE VOGEL GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management; Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $45,600

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · first_quarter · Firm: THE VOGEL GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management; Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $45,600

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2023 · fourth_quarter · Firm: THE VOGEL GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $44,100

Matched citations: S.1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2023 · fourth_quarter · Firm: THE VOGEL GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

Client expense: — · Firm income: $44,100

Matched citations: S.1339

Source: Senate LDA